Harmful Products: Punishing Companies for Public Health Damage

Dec.08.2022
Harmful Products: Punishing Companies for Public Health Damage
FDA proposes to reduce nicotine levels in cigarettes while a jury orders Philip Morris to pay billions in compensation.

In the United States, there are numerous companies producing products that are harmful to public health, such as oil producers, opiate manufacturers, e-cigarette and tobacco industry giants.


The US Food and Drug Administration (FDA) has proposed that tobacco companies be forced to lower the nicotine content in cigarettes in order to make them less addictive.


In September, a Massachusetts jury ordered Fimo International to pay over $8 million in compensatory damages and $1 billion in punitive damages for causing Fontaine's (name of deceased) lung cancer and death. This is the first multi-billion dollar punitive damages verdict in the state’s history. Fimo International has stated that the verdict is "clearly excessive" and vows to fight it.


Decades ago, Philip Morris International had the option to reduce nicotine levels in their products to make them less addictive. Instead, the company continued to produce deadly cigarettes despite knowing that they kill about 500,000 Americans every year. As demonstrated in the Fontaine case where she smoked Marlboro and other cigarettes, Philip Morris International continued to use harmful ingredients in their products.


To alter electronic cigarette products that harm public health, a system of punishment or reward is necessary to regulate the actions of e-cigarette companies. Electronic cigarette companies, worth billions of dollars, do not take lightly six or seven-figure fines, but fines in the tens of millions may be enough to make them cautious.


In the Fontaine case, the jury took a completely rational approach in search of a system that could both "punish and deter," resulting in the fine imposed on Femor International. In fact, imposing hefty fines in public health cases is a way to change the behavior of unscrupulous companies.


2FIRSTS will continue to report on this issue, with further updates available on the '2FIRSTS APP.' Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

RLX Technology 2025 Revenue Rises 44.0% YoY to Nearly USD 566.1 million, International Business Accounts for 76.5% in Q4
RLX Technology 2025 Revenue Rises 44.0% YoY to Nearly USD 566.1 million, International Business Accounts for 76.5% in Q4
RLX Technology Inc. announced its unaudited financial results for the fourth quarter and full year of 2025. Q4 net revenue reached RMB 1.1413 billion, a 40.3% year-over-year increase, while full-year net revenue grew 44.0% to RMB 3.9589 billion.
Mar.13 by 2FIRSTS.ai
Spain’s Galicia Moves First: Under-18 Vape and Energy Drink Sales and Use Banned
Spain’s Galicia Moves First: Under-18 Vape and Energy Drink Sales and Use Banned
Galicia will implement a new “Minor Health Protection and Addictive Behaviors Prevention” law this Saturday, becoming the first region in Spain to ban the sale and use of vapes for people under 18.
Mar.09 by 2FIRSTS.ai
European Commission Publishes Tobacco Control Framework Evaluation, Says Smoking and Tobacco-Related Deaths Have Declined
European Commission Publishes Tobacco Control Framework Evaluation, Says Smoking and Tobacco-Related Deaths Have Declined
The European Commission has published its evaluation of the EU tobacco control framework, assessing the effectiveness, efficiency and relevance of the Tobacco Products Directive and Tobacco Advertising Directive in protecting public health and ensuring the smooth functioning of the internal market.
Apr.03 by 2FIRSTS.ai
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
According to a complaint filed on March 17 in the U.S. District Court for the Northern District of Texas, Fontem US, LLC and Texas retailer OM Investment, LLC sued the Food and Drug Administration and the Department of Health and Human Services over FDA’s refusal-to-file decision for certain Zone nicotine pouch PMTAs.
Mar.19 by 2FIRSTS.ai
FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
Casey’s, the No. 3 U.S. C-Store Chain, Sees Nicotine Category Shift as Pouches Rise 31% and Vapor 12%
Casey’s, the No. 3 U.S. C-Store Chain, Sees Nicotine Category Shift as Pouches Rise 31% and Vapor 12%
Casey’s General Stores (NASDAQ: CASY) reported accelerating growth in modern nicotine products during its fiscal third quarter ended January 31, 2026. Nicotine pouch sales increased 31% year over year, while vapor products rose 12%. Although cigarette unit sales continued to decline, management stated that the rate of decline slowed compared to prior quarters.
Market
Mar.15